《Journal Of Neuroengineering And Rehabilitation》重点专注发布工程技术-工程：生物医学领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。根据网友分享的投稿经验，平均审稿速度为 约24月 。该杂志创刊至今，在工程技术-工程：生物医学领域，影响力非凡，对来稿文章质量要求很高，稿件投稿过审难度很大，刊登文章的学术水平和编辑质量在同类杂志中均名列前茅。如果你想在该杂志上发表论文，你可以向编辑部提交文章，但文章必须具有重要意义并代表该领域专业的发展。我们欢迎广大同领域的研究者提交投稿。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 9.6 | 1.291 | 1.89 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：Rehabilitation
|
Q1 | 1/161 | 99% | |||
|
大类：大类：Medicine
小类：小类：HealthInformatics
|
Q1 | 22/138 | 84% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：ENGINEERING, BIOMEDICAL | SCIE | Q1 | 25 / 122 | 79.9% |
| 学科：NEUROSCIENCES | SCIE | Q1 | 46 / 310 | 85.3% |
| 学科：REHABILITATION | SCIE | Q1 | 4 / 169 | 97.9% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：ENGINEERING, BIOMEDICAL | SCIE | Q1 | 17 / 122 | 86.48% |
| 学科：NEUROSCIENCES | SCIE | Q1 | 37 / 310 | 88.23% |
| 学科：REHABILITATION | SCIE | Q1 | 17 / 169 | 90.24% |
文章名称
引用次数
Rehabilitation robots for the treatment of sensorimotor deficits: a neurophysiological perspective
37
Soft robotic devices for hand rehabilitation and assistance: a narrative review
28
Assisting hand function after spinal cord injury with a fabric-based soft robotic glove
22
What do randomized controlled trials say about virtual rehabilitation in stroke? A systematic literature review and meta-analysis of upper-limb and cognitive outcomes
20
Safety of long-term electricalperipheral nerve stimulation: review of the state of the art
19
Shaping neuroplasticity by using powered exoskeletons in patients with stroke: a randomized clinical trial
16
Autonomous multi-joint soft exosuit with augmentation-power-based control parameter tuning reduces energy cost of loaded walking
16
Machine learning algorithms for activity recognition in ambulant children and adolescents with cerebral palsy
15
fNIRS-based Neurorobotic Interface for gait rehabilitation
15
Generalizing remotely supervised transcranial direct current stimulation (tDCS): feasibility and benefit in Parkinsons disease
14
国家/地区
发文量
TUSA
158
TCanada
55
TGERMANY (FED REP GER)
47
TItaly
46
TSwitzerland
45
TNetherlands
36
TEngland
33
TSpain
31
TSouth Korea
20
TAustralia
19
